| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | US20100086528 Novel bacteria isolated from fresh honey or the honey producing tract of honey bees |
| 04/08/2010 | US20100086525 Compositions and Methods for Altering Pancreas or Liver Function |
| 04/08/2010 | US20100086496 Oral care package |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/08/2010 | DE10237317B4 Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung An enzyme-containing composition, to processes for their preparation and their use |
| 04/08/2010 | CA2739513A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative |
| 04/08/2010 | CA2739050A1 Antibodies against il-25 |
| 04/08/2010 | CA2738985A1 Therapeutic agent for hepatitis c |
| 04/08/2010 | CA2737522A1 Guanylhydrazones for treatment of postoperative intestinal inflammation |
| 04/07/2010 | EP2172541A1 Method for production of hepatic-lobule-like cell mass from adipose-tissue-derived cell |
| 04/07/2010 | EP2172488A1 Material with immunogenicity |
| 04/07/2010 | EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| 04/07/2010 | EP2172226A1 Method of fixing and expressing physiologically active substance |
| 04/07/2010 | EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound |
| 04/07/2010 | EP2172217A1 Fibrosis inhibitor |
| 04/07/2010 | EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains |
| 04/07/2010 | EP2170930A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 04/07/2010 | EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 04/07/2010 | EP2170380A1 Capsid proteins and uses therefore |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP2170305A1 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
| 04/07/2010 | EP2170072A1 Farnesoid x receptor agonists |
| 04/07/2010 | EP1590047B1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs |
| 04/07/2010 | CN1973872B Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn |
| 04/07/2010 | CN1915223B Chewing tablet of compound aluminum magnesium hydroxide, preparation method and method for measuring quality |
| 04/07/2010 | CN1813753B Low dose entecavir formulation and use |
| 04/07/2010 | CN1617733B Method of treatment of gastrointestinal disease and polymeric composition for use therein |
| 04/07/2010 | CN1582921B Use and medicinal composition of eremophilane lactone for inhibiting hepatitis B virus |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN101691568A Method of producing edible immobilized active probiotics |
| 04/07/2010 | CN101691550A Microbial inoculum for improving water body and structure of biological intestinal colony, and preparation method and application thereof |
| 04/07/2010 | CN101690801A Application of interleukin-1 receptor antagonist and medicinal composition thereof |
| 04/07/2010 | CN101690787A Traditional Chinese medicine for treating chronic gastritis and gastric ulcer |
| 04/07/2010 | CN101690786A Traditional Chinese medicine for treating chronic gastritis |
| 04/07/2010 | CN101690775A Medicament having qi-supplementing, blood-nourishing, kidney-boosting, yang-reinforcing and anti-cancer effects |
| 04/07/2010 | CN101690771A Medicine for curing chronic enteritis |
| 04/07/2010 | CN101690763A Nutrition type tonification yang-strengthening medicinal liquor |
| 04/07/2010 | CN101690757A Method for preparing bezoar supernatant preparations |
| 04/07/2010 | CN101690756A Method for detecting cholecytitis rehabilitation capsules |
| 04/07/2010 | CN101690739A Preparation method of dogbane leaf extractive |
| 04/07/2010 | CN101690735A Complex microorganism health-protection agent and preparation method thereof |
| 04/07/2010 | CN101690588A Composition comprising probiotics and tea extract and application thereof |
| 04/07/2010 | CN101273973B Pharmaceutical combination containing Mosapride citrate |
| 04/07/2010 | CN101130012B Medicine composition for treating toothache and method of preparing the same |
| 04/07/2010 | CN101062221B Medicine for treating gastric ulcer and duodenal ulcer |
| 04/07/2010 | CN101057924B Umbilicus medicine for treating abdominal distension and preparing process thereof |
| 04/07/2010 | CN101011442B Barrenwort extract fat emulsion composition and its preparing process |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 04/06/2010 | US7691878 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 04/06/2010 | US7691875 Imidazopyridine compounds, processes for their preparation and therapeutic uses thereof |
| 04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
| 04/06/2010 | US7691828 Compositions for ameliorating fecal properties |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691387 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/06/2010 | CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 04/01/2010 | WO2010036876A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 04/01/2010 | WO2010036631A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036630A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010035833A1 Therapeutic agent for tympanites in ruminant animal |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035751A1 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 04/01/2010 | WO2010034243A1 Novel gene cluster |
| 04/01/2010 | WO2010014836A3 Tgr5 modulators and methods of use thereof |
| 04/01/2010 | WO2010005836A9 Use of rifalazil to treat colonic disorders |
| 04/01/2010 | WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/01/2010 | WO2009071993A3 Pharmaceutical compositon for cleansing of the bowel |
| 04/01/2010 | WO2008139845A8 Novel amide derivative |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081702 Pharmaceutical composition for prophylaxis or treatment of hepatitis |
| 04/01/2010 | US20100081701 FAP inhibitors |
| 04/01/2010 | US20100081672 Ph sensitive matrix formulation |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081631 Methods and compositions for treating gastrointenstial disorders |
| 04/01/2010 | US20100080822 treating menstrual cramps by administering composition of extracts from stem of Cinnamomum cassia, sclerotium of Poria cocos, root bark of Paeonia suffruticosa, root of Paeonia lactiflora and seed of Prunus persica or Prunus davidiana; composition comprises1.3-1.9% Paeoniflorin and 0.7-1.1% Paeonol |
| 04/01/2010 | US20100080782 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/01/2010 | DE19943491B4 Verbesserte Komprimate Improved compressed |
| 04/01/2010 | CA2738819A1 Bloat therapeutic agent for a ruminant |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 04/01/2010 | CA2737645A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2737639A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2736285A1 Agent for preventing and/or treating functional gastrointestinal disorder |
| 03/31/2010 | EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
| 03/31/2010 | EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 03/31/2010 | EP2168577A1 Drug having effect of promoting hepatocyte growth |